Global 2,3-dichloropyridine Market is valued approximately USD 23.95 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.80 % over the forecast period 2021-2027. The 2,3-Dichloropyridine is an organohalide, in which one or more carbon atoms are linked with each other and it is one of the isomers of dichlorpyridine. It is produced by direct reaction of pyridine with chlorine. It comes under the group of synthetic organic compounds that are widely used in the pharmaceutical industry. It is a chemical used as an agrochemical intermediate. as well as pharmaceutical intermediate. 2,3-Dichloropyridine is used in the form of reagent for the preparation of substituted 3-(5-membered heterocycle-carboxamido) pyridine derivatives for treatment of autoimmune and inflammatory diseases such as type 1 diabetes, multiple sclerosis (MS), graves disease and others. Therefore, rising prevalence of autoimmune and inflammatory diseases is growing the market demand for 2,3-dichloropyridine. For instance, according to Centers for Disease Control and Prevention (CDC) report 2020, the number of people diagnosed with type 1 diabetes in 2020 in America reached 1.6 million as compared to 1.25 million in 2017, which is an increase of approximately 30%. Also, according to British Society for Immunology report 2018, year-on-year rate of increasing incidence of four autoimmune conditions are as follows: - Rheumatic diseases such as rheumatoid arthritis - 7.0% increase per year; Neurological disease such as MS 3.7% increase per year; Endocrinological conditions such as type 1 diabetes 6.3% increase per year and Coeliac disease 4-9% increase per year.
The regional analysis of global. Medium-chain triglycerides market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to increasing prevalence of autoimmune & inflammatory diseases such as Rheumatoid arthritis, osteoarthritis, Type 1 diabetes, Lupus SLE and others. Whereas, Asia-Pacific is also anticipated to exhibit fastest growth rate over the forecast period 2020-2027. Factors driving are growing geriatric population and rising agriculture sector would create profitable growth prospects for the Medium-chain triglycerides market across Asia-Pacific region.
Major market player included in this report are:
GLENTHAM LIFE SCIENCES LIMITED
JUBILANT LIFE SCIENCE
GREEN CHEMICALS CO., LTD.
JVR FINE CHEMIE PVT LTD
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year 2018, 2019
Base year 2020
Forecast period 2021 to 2027
Target Audience of the Global 2,3-dichloropyridine Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers